香港, 2025年1月2日 - (亞太商訊 via SeaPRwire.com) - 經過多年的爆發式增長後，現製飲品市場的競爭依舊激烈。在眾多品牌中，蜜雪冰城的表現引起了市場的關註。作為中國及全球最大的現製飲品龍頭（以截至2024年9月30日門店數計），蜜雪冰城在規模、供應鏈、品牌力等方面構築了良好的競爭優勢，穩居行業領先地位。1月1日，蜜雪冰城更新港股A1招股書，其業務表現又有哪些新的突破？國內國外穩步擴張 門店數躍居全球第一隨著行業度過跑馬圈地的高速擴張期，如何挖掘新的業務增量，已成為頭部品牌們面臨的一道必答題。蜜雪冰城通過聚焦下沉與出海這兩大極具發展潛力的市場，穩步推進其門店擴張戰略，捕捉市場發展機遇。國內市場方面，蜜雪冰城憑藉廣泛的門店網絡，持續滲透三四線以及鄉鎮下沉市場。截至2024年9月30日，公司在中國內地的門店數超過40,000家，覆蓋超過300個地級市、1,700個縣城和4,900個鄉鎮，其中超過23,000家位於三線及以下城市，占比達到57.2%。在國內穩居市場鰲頭的同時，蜜雪冰城積極響應一帶一路倡議，積極進軍海外市場。截至2024年9月30日，公司在中國內地以外擁有約4,800家門店，包括印尼、越南、馬來西亞、泰國、菲律賓、柬埔寨、老撾、新加坡、澳大利亞、韓國和日本11個國家以及香港和澳門地區。其中，越南和印尼兩國開店數量分別超過1,300家及2,600家，成為公司國際化佈局的主力。得益於國際國內的同步發力，2024前九個月，蜜雪冰城淨增門店數超過7,700家（相較於2023年底）。截至2024年9月30日，公司門店數超過45,000家，就門店數量而言，蜜雪冰城已超越星巴克，成為中國以及全球最大的現制飲品企業。門店表現亮眼 業績高基數之上延續增長值得一提的是，蜜雪冰城並非單純追求門店數量的增長，而是經過深入研究市場需求、消費趨勢之後的精心佈局，這使其新開門店能夠快速站穩腳跟，為可持續發展奠定堅實基礎。從2024年前9個月的平均單店日均終端營業額看，2024年新開業的門店平均單店日均終端營業額表現不輸老店。同時，蜜雪冰城老店的運營表現也十分穩健。得益於精準的市場洞察、持續的產品創新、高效的供應鏈管理以及強大的市場口碑，老店（2021年或之前開業門店）的平均單店日均終端營業額在2021年至2023年期間仍呈現年化4%以上的增長，2023年及以前開業的門店在2024年前九個月的平均單店日均終端營業額均超過2023年全年的水平。在高效門店擴張戰略的支持下，蜜雪冰城在過往較高業績基數的基礎上，依然實現了收入、利潤的雙雙增長，盈利能力進一步提升。2024年前9個月，實現收入人民幣187億元，同比增長超過21%；淨利潤人民幣35億元，同比增長超過42%。毛利率為32.4%，同比提升2.7個百分點；净利率為18.7%，同比提升2.8個百分點。中長期看，隨著城鎮化的持續推進以及居民收入水平的提升，現製飲品消費數量和消費能力將不斷增長，為行業發展提供廣闊的市場空間。蜜雪冰城以高性價比產品俘獲用戶心智，國內市場持續深耕下沉市場，將進一步鞏固其領先優勢，同時，國際化戰略的深入推進也將為公司打造新的增長引擎。在國內國際市場共同驅動下，蜜雪冰城有望釋放更大的增長彈性。 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港, 2025年1月2日 - (亞太商訊 via SeaPRwire.com) - 縱橫公共關係顧問集團 (簡稱「縱橫公關集團」或「集團」) 今日欣然宣佈正式邁入集團成立30周年的輝煌時刻。為紀念這一里程碑，集團推出各種活動以示慶祝，其中包括已於2024年底圓滿落幕的30周年標誌設計比賽。通過設計比賽的激烈角逐，一款印有「30」數字和地球元素的標誌脫穎而出，它象徵著集團全球佈局之專業團隊，以及為全球客戶提供卓越服務的堅定承諾。這款標誌將於2025 年起廣泛應用於集團的各種宣傳和推廣材料，成為集團30周年誌慶的標誌性符號。2025年首個工作日，縱橫公關集團以別出心裁的慶祝活動拉開周年誌慶的序幕，為同事們準備了珍珠奶茶、茶點以及舒適的按摩服務，旨在為新的一年注入活力。縱橫公關集團主席及創辦人曾立基在慶典上表示：「珍珠的璀璨光澤，象徵著時間的沉澱與磨礪，正如縱橫公關集團經歷30年來的蓬勃發展。在過去30年間，我們見證了全球政經格局的複雜多變，面對重重挑戰，我們始終堅韌不拔。而正是這份韌性和適應能力，讓我們不僅跨躍挑戰，更從香港一間本地公司，躋身於亞太地區頂尖的公關集團之列，擁有旗下成員公司20家。我們的業務範疇也從最初專注的金融服務，擴展到更為全面的綜合解決方案，使我們在瞬息萬變的市場中獨樹一幟。」縱橫公關集團一直致力於業務據點和範疇的擴展，同時堅守提供卓越服務和追求進步的核心精神。2024年，集團邁向研究領域的重要一步，由在研究範疇的專精學者帶領，專注於環境、社會和管治(「ESG」)議題的研究。憑藉團隊的學術積累和對全球趨勢的深刻洞察為客戶提供更具針對性的專題調研，並據此制訂解決方案。集團認為，這一新服務不僅能滿足現有客戶的需求，更能吸引更多潛在客戶，推動集團業務向多元化發展。集團的創意服務和數位內容創作旗艦Strategic DigitaLab(簡稱「SDL」) (www.strategicdigitalab.com)自2017年成立以來，不斷引領創新潮流。2024年，SDL更是致力於重塑品牌形象，憑藉其卓越的敘事能力，在多元平台全面發力，成功帶動客戶尋求高效、大規模的內容創作服務，以滿足、啟發和鼓動目標受眾。通過共享創意和數位能力，SDL使集團在瞬息萬變的時代中佔據先機，充分滿足了各大客戶的多樣化需求。而為了配合在南半球的客戶需要，集團於2024年全面收購了Financial & Corporate Relations Pty Limited (「FCR」) 。FCR是澳大利亞一家擁有40年歷史的顧問公司，專注於投資者、企業及財經傳訊領域。集團對這次收購充滿期待，相信FCR將為集團帶來業務上的全新突破。多年來，集團始終秉持對服務品質的極致追求，也因此收穫了超過540個獎項和殊榮，包括亞太區最佳公關集團、最佳公關顧問(亞太區及亞洲)、大中華最佳獨立顧問公司、香港最佳公關顧問、亞太區最佳財經公關顧問、最佳危機管理團隊及市場領袖大獎等。集團主席曾立基表示：「感謝每一位同事的堅持不懈和團隊的合作無間，讓我們能夠濟濟一堂共同慶祝30周年這一重要時刻。展望未來，集團將繼續在公關領域精益求精，尋求創新，不斷提升服務品質，積極擁抱自動化和新科技；為團隊提供全面的培訓，並積極探索新的業務領域。同時，作為企業公民的堅定倡導者，我們也將繼續積極參與公益活動和義務公關工作，為社會貢獻我們的力量。」關於縱橫公共關係顧問集團 (「縱橫公關集團」)縱橫公關集團於1995年在香港成立之時以投資者關係服務為核心，至今已發展成為輻射亞太區、服務本地及國際客戶的綜合公關顧問。集團在亞太區8大據點聘有超過250名公關專才，同時透過分佈世界各地的夥伴和PROI Worldwide，在逾165個城市為客戶提供一站式綜合傳訊服務。 歡迎流覽網站: www.sprg.asia垂詢縱橫財經公關顧問有限公司溫淑賢電話: (852) 2864 4822電郵: eveline.wan@sprg.com.hk網址: www.sprg.asia香港 | 北京 | 上海 | 廣州 | 台北 | 新加坡 | 吉隆玻 | 悉尼 Copyright 2025 亞太商訊 via SeaPRwire.com.

上海, 2025年1月2日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀（HKEX 1952.HK）是一家專注于創新藥研發、臨床開發、製造和商業化的生物製藥公司，今日宣佈隨著《國家基本醫療保險、工傷保險和生育保險藥品目錄（2024年）》（「國家醫保藥品目錄」）2025年1月1日正式實施，耐賦康(R)（布地奈德腸溶膠囊，NEFECON(R)）將開始執行醫保新價格，各地IgA腎病患者將陸續享受醫保報銷。耐賦康(R)於2024年11月被納入國家醫保藥品目錄。作為全球首個獲得美國食品藥品監督管理局（FDA）和歐洲藥品管理局（EMA）完全批准的IgA腎病治療藥物，耐賦康(R)於2023年11月通過優先審評程式正式獲得中國國家藥品監督管理局的批准，用於治療具有進展風險的原發性IgA腎病成人患者，是中國唯一獲得IgA腎病適應症的治療藥物。根據國家醫保局要求，耐賦康(R)將於1月開始在北京、上海等各省市執行醫保報銷，患者可在定點醫療機構或定點藥店購藥，並享受醫保報銷價格。國家醫保藥品目錄的正式實施將提升耐賦康(R)的可及性，減輕患者負擔，使更多中國IgA腎病患者從這款創新藥物中獲益。耐賦康(R)全球III期臨床試驗NefIgArd研究中國人群資料分析顯示，耐賦康(R)減少66%的腎功能下降，預估可將疾病進展至透析或腎移植的時間延緩12.8年。憑藉創新的作用機制和臨床優勢，耐賦康(R)已經得到了國內外多個權威治療指南的推薦，包括被納入由改善全球腎臟病預後組織（KDIGO）發佈的《2024版KDIGO IgA腎病和IgA血管炎臨床管理實踐指南（公開審查版）》，並被指是迄今為止唯一被證明可以降低致病性IgA和IgA免疫複合物水準的治療方法。關於耐賦康(R)（NEFECON(R)）耐賦康(R)(NEFECON(R))是布地奈德腸溶膠囊，作為全球首個對因治療IgA腎病的藥物，是靶向腸道黏膜B細胞的免疫調節劑，能減少50%腎功能下降1，在中國人群中能延緩腎功能衰退達66%2，預計將疾病進展至透析或腎移植的時間延緩了12.8年3。同時布地奈德首過代謝程度達90%4，具有良好的安全性。耐賦康(R)專為IgA腎病患者研製，每顆膠囊含布地奈德4mg，通過特殊的遲釋及緩釋雙重製劑工藝，將布地奈德靶向釋放於回腸末端的黏膜B細胞（包括派爾集合淋巴結），膠囊溶解後，三層包衣微丸持續穩定釋放布地奈德，高濃度覆蓋整個靶區域，從而減少誘發IgA腎病的半乳糖缺陷的IgA1抗體（Gd-IgA1）產生，進而干預發病機制上游階段，達到治療IgA腎病的作用。2019年6月，雲頂新耀與Calliditas Therapeutics 簽訂獨家授權授權合約，獲得在大中華地區和新加坡開發以及商業化耐賦康(R)的權利。該協議於2022年3月擴展，將韓國納入雲頂新耀的授權許可範圍。關於雲頂新耀雲頂新耀是一家專注於創新藥和疫苗研發、臨床開發、製造和商業化的生物製藥公司，致力於滿足亞洲市場尚未滿足的醫療需求。雲頂新耀的管理團隊在中國及全球領先製藥企業從事過高質量研發、臨床開發、藥政事務、化學製造與控制（CMC）、業務發展和商業化運營，擁有深厚的專長和豐富的經驗。雲頂新耀已打造多款疾病首創或者同類最佳的藥物組合，公司的治療領域包括腎科疾病、感染性和傳染性疾病、自身免疫性疾病。有關更多信息，請訪問公司網站：www.everestmedicines.com。前瞻性聲明本新聞稿所發佈的信息中可能會包含某些前瞻性表述，乃基於本公司或管理層在做出表述時對公司業務運營情況及財務狀況的現有看法、相信、和現有預期，可能會使用「將」、「預期」、「預測」、「期望」、「打算」、「計劃」、「相信」、「預估」、「確信」及其他類似詞語進行表述。這些前瞻性表述並非對未來業績的保證，會受到風險、不確定性及其他因素的影響，有些乃超出本公司的控制範圍，難以預計。因此，受我們的業務、競爭環境、政治、經濟、法律和社會情況的未來變化及發展等各種因素及假設的影響，實際結果可能會與前瞻性表述所含資料有較大差別。本公司及各附屬公司、各位董事、管理人員、顧問及代理未曾且概不承擔更新該稿件所載前瞻性表述以反映在本新聞稿發布日後最新信息、未來項目或情形的任何義務，除非法律要求。參考文獻1.Lafayette R,et al. Lancet. 2023 Sep 9;402(10405):859-870.2.2023ASN. Oral presentation.3.Jonathan Barratt,et al. 2023 ASN. Poster no. SA-PO886.4.Edsbäcker S,et al. Aliment Pharmacol Ther. 1999 Feb;13(2):219-24. Copyright 2025 亞太商訊 via SeaPRwire.com.

SINGAPORE, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) - AEM Holdings Ltd. (“AEM” or “the Group”), a global leader in test innovation, today announced the appointment of Kwek You-Cheer as its new Chief Financial Officer (“CFO”) with effect from 2 January 2025. Mr. Kwek has over 20 years’ experience in strategic financial leadership and operations internationally, which positions him well to guide AEM’s financial strategy and drive operational efficiency across the Group.Kwek You-CheerMr. Kwek joins AEM from Lenovo Group’s Asia Pacific Infrastructure Solutions Group (ISG), where he served as CFO. Prior to Lenovo, Mr. Kwek spent time as CFO at Microsoft Hong Kong and in a variety of finance roles in over a decade at Schneider Electric.Mr. Kwek graduated from Nanyang Technological University with a Bachelor of Accountancy (Honours).Ms. Amy Leong, Chief Executive Officer of AEM, commented, “We are pleased to have Mr. Kwek join the team, and believe his experience and knowledge will be an invaluable asset to the team in helping us achieve robust growth with a focus on improved operational efficiency.”About AEM Holdings Ltd.AEM is a global leader in test innovation. We provide the most comprehensive semiconductor and electronics test solutions based on the best-in-class technologies, processes, and customer support. AEM has a global presence across Asia, Europe, and the United States. With manufacturing plants located in Singapore, Malaysia (Penang), Indonesia (Batam), Vietnam, and Finland (Lieto), South Korea, and the United States (Tempe) and a global network of engineering support, sales offices, associates, and distributors, we offer our customers a robust and resilient ecosystem of test innovation and support.AEM Holdings Ltd. is listed on the main board of the Singapore Exchange (Reuters: AEM. SI; Bloomberg: AEM SP). AEM’s head office is in Singapore.Issued for and on behalf of AEM Holdings Ltd. by Financial PR Pte LtdFor more information please contact:Kamal SAMUEL / Shivam SARAFFinancial PR Pte LtdTel: 6438 2990 / Fax: 6438 0064E-mail: kamal@financialpr.com.sg / shivam@financialpr.com.sg Copyright 2025 ACN Newswire via SeaPRwire.com.

WINCHESTER, ENGLAND, Jan 3, 2025 - (ACN Newswire via SeaPRwire.com) - Millions of people try vegan diets each January as part of the global Veganuary campaign. In 2024, roughly 25 million people sought a fresh start for their health and the environment through vegan diets. Yet in the decade since Veganuary was founded in 2014, dogs and cats have been almost entirely excluded. Now however, veterinary Professor Andrew Knight is calling for Veganuary to be extended to pets.Writing in The Conversation, Knight notes that dogs and cats may also experience health benefits associated with vegan diets: "By late 2024, 11 studies in dogs, three in cats, and one systematic review covering both had all demonstrated that dogs and cats thrive on modern vegan or vegetarian diets. Certain health benefits appear consistent, such as a reduction in obesity and of conditions that may be triggered by animal-sourced allergens, like itchy skin and ears and gastrointestinal problems." However, he notes that "all diets, including vegan diets, should be manufactured by reputable pet food companies which carefully formulate their food to be nutritionally sound."Professor Knight is a very experienced dog and cat veterinarian with a PhD in vegan pet food. His most recent study examined the environmental benefits of such diets. These shattered long-standing assumptions that it is only people who need to change their diets for environmental reasons.Knight found that in nations with high pet ownership - such as the US, pet food consumes around 20% of all land animals killed for food, as well as billions of fish and marine animals. Globally, it's around 9% - even after accounting for the use of by-products of human food production.This means at least six billion land animals are killed each year to feed the world's approximately 470 million pet dogs. Use of nutritionally sound vegan dog food would provide enormous savings of land and fresh water, which could be used for reforestation, re-wilding, biodiversity increase, and carbon capture. It would spare a staggering 0.57 gigatonnes (1 gigatonne is 1 billion tonnes) of CO2-equivalent greenhouse gases each year - 1.5 times the 0.38 gigatonnes emitted by the whole of the UK in 2023.Because most plant calories fed to livestock animals are lost during conversion to meat, milk or eggs, directly consuming plant-based ingredients can also save food energy. A global transition to vegan dog food would spare sufficient food energy to feed around 450 million people annually - or the entire human population of the EU.Sustainability benefits are large even considering the world's roughly 370 million pet cats. A global transition to nutritionally sound vegan cat food would spare sufficient food energy to feed around 70 million people annually - larger than the human population of the UK.Said Knight, "An average-sized dog can consume as much meat as a person. If you want better health and environmental outcomes in 2025, try Veganuary - and please don't forget your pets!" Advice is available via his website.Contact InformationAndrew KnightVeterinary Professor of Animal Welfareandrew.knight@murdoch.edu.auSOURCE: Representing Animals Foundation Copyright 2025 ACN Newswire via SeaPRwire.com.

- Themed “New Play for All”, the three international events bring together over 2,500 exhibitors from 34 countries and regions- Toys & Games Fair's Electronic & Remote Control Toys and Educational Toys & Games zones have expanded, in addition to the debut of an ESG pavilion- Record number of exhibitors at Hong Kong Baby Products Fair- HKTDC organised over 200 buying missions from more than 40 countries and regions to Hong Kong for sourcingHONG KONG, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) – Kicking off a brand new year, the 51st HKTDC Hong Kong Toys & Games Fair, the 16th HKTDC Hong Kong Baby Products Fair and the 23rd Hong Kong International Stationery & School Supplies Fair will all be held at the Hong Kong Convention and Exhibition Centre from 6 to 9 January. The Hong Kong Toys & Games Fair and Hong Kong Baby Products Fair are organised by the Hong Kong Trade Development Council (HKTDC), while the Hong Kong International Stationery & School Supplies Fair is jointly organised by the HKTDC and Messe Frankfurt (HK) Ltd.Sophia Chong, HKTDC Deputy Executive Director, said: “Themed New Play for All, the three fairs attracted more than 2,500 exhibitors from 34 countries and regions, including pavilions from Hong Kong, Mainland China, Taiwan, Korea, and Europe. We have also invited more than 200 buying missions from over 40 countries and regions to Hong Kong for sourcing, creating new opportunities for the industry and injecting new momentum into Hong Kong's economic development.The Toys & Games Fair and Baby Products Fair continue to feature the popular ‘Brand Name Gallery’, with 40% more brands compared to last year, and totalling more than 380 famous toys, baby and children's brands, enabling buyers to source the latest designs and quality products.”Asia's flagship toy fair sees expansion in two major exhibition zonesAs the flagship toy fair in Asia and the HKTDC’s first trade show of the year, the Hong Kong Toys & Games Fair, along with the Hong Kong Baby Products Fair and the Hong Kong International Stationery & School Supplies Fair, bring cross-industry business opportunities to visitors from diverse sectors.This year's Toys & Games Fair sees an expansion in exhibition space in two major zones. This includes the Electronic & Remote Control Toys and Educational Toys & Games zones.The Green Toys zone makes a welcome return and will showcase eco-friendly and innovative products.In addition, many exhibitors have introduced toys that incorporate green elements and promote environmental awareness in recent years. Both the Toys & Games Fair and the Stationery & School Supplies Fair will feature "Green Leaf" label on-site to facilitate buyers in sourcing related products.Funded by the Trade and Industrial Organisation Support Fund of the Trade and Industry Department, HKSAR Government, the Toys Manufacturers’ Association of Hong Kong and FHKI Group 19 (Hong Kong Toys Council) will present the first ESG Pavilion showcasing toys incorporating Environment, Social and Governance (ESG) elements, including products made entirely from eco-friendly or recycled materials. Exhibitors are using various creative methods to promote sustainable development, emphasising the value of social responsibility and ESG fundamentals.This year’s Toys Fair has an impressive pavilion lineup, including those from Mainland China, Taiwan, Korea, and the Spielwarenmesse eG’s World of Toys Pavilion which will host various European exhibitors. The Hong Kong Brand Toy Association (HKBTA) Pavilion once again promotes the local creative industry and trendy toy products to international buyers.The Smart Tech Toys & Games zone will feature tech products operated by applications, incorporating virtual reality (VR), augmented reality (AR), mixed reality (MR) and other technologies. Kidult World will showcase toys specifically designed for adults with a childlike spirit, such as collectibles, magic props, models, and puppets.Record number of exhibitors at Baby Products FairWith more than 660 exhibitors, this year's Hong Kong Baby Products Fair boasts the most exhibitors ever. The popular ODM Strollers and Gear zone continues for the second consecutive year, featuring over 80 exhibitors, making it easier than ever for buyers to source products from original design manufacturers. The Selection of Europe pavilion returns and will feature, for the first time, the UK’s Baby Products Industry Association putting a spotlight on quality European baby brands and products. This year sees the return of several popular pavilions, such as the well-known Korean and Hong Kong Children, Babies, Maternity Industries Association pavilions. Making their debut this year is the Zhejiang Zhili pavilion which will present an array of high-quality infant and children’s clothing.The Toys & Games Fair and Baby Products Fair continue to feature the popular Brand Name Gallery, bringing together over 380 well-known brands from around the globe, allowing buyers to source the latest designs and high-quality products from a variety of brands.Jointly organised by the HKTDC and Messe Frankfurt (HK) Ltd, the Hong Kong International Stationery & School Supplies Fair will feature the latest school and office supplies, creative art supplies and gift stationery. The organisers continue to cooperate with renowned industry associations in different regions, including China Stationery & Sporting Goods Association, Malaysia Stationery Importers and Exporters Association and The Federation of Stationers and Booksellers Association of Malaysia.Asian Toys & Games Forum and various seminars help the industry seize opportunitiesHelping buyers and sellers broaden their business networks and learn about the most recent market trends, there are a number of networking events, buyer forums, product demo and launch pad, and seminars throughout the fair period.On the second day of the fair, the Asian Toys & Games Forum will be held. Themed Beyond Fun and Play: Fostering Social Responsibility in the Toy Industry, international toy and game industry experts will discuss the role of toys and games in therapy, healthcare and wellness, and their impact on socialisation and active ageing. Other seminars will cover popular topics such as toy safety regulations, toy sustainability, and gender-based perspectives and inclusivity in the toy market.The three exhibitions offer buyers a one-stop sourcing platform, creating more cross-industry business opportunities. Under the EXHIBITION+ model, the fairs integrate physical exhibition and the Click2Match smart business matching platform for online business meetings. The online exhibition will be early accessible from 30 December 2024 until 16 January 2025, to sustain and create greater business opportunities for the industry. Buyers can also scan QR codes at exhibitor booths using the Scan2Match service to bookmark their favourite exhibitors, browse product information and engage with exhibitors even after the fair to make for more business connections.Photo Download:https://bit.ly/4fLhGt0Sophia Chong, HKTDC Deputy Executive Director (centre), Bryant Chan, Chairman of the HKTDC Toys Advisory Committee (left) and Judy Cheung, Deputy General Manager of Messe Frankfurt (HK) Ltd (right), attended the press conference presenting highlights and innovative products of the Toys & Games Fair, Baby Products Fair and Stationery & School Supplies Fair, which will open next Monday (6 January).One green toy at the Toys & Games Fair is the “Voice of Nature” 3D paper puzzle. The product comes with multiple movable joints. By gently shaking the product, it mimics the sound of animals. The puzzle, instruction manual and packaging are all made from pure wood pulp kraft paper, making the entire product recyclable and minimising environmental damage.The officially authorised 1/64 scale Super Car Collection Lamborghini Essenza SCV12 model.Gateway Space Station Interactive Model is a STEM learning toy, and a detailed replica of Gateway; a part of the NASA Artemis project.An exhibitor at the Baby Products Fair showcases the lightweight and portable 2anagels Silicone Diamond Suction Baby Bowl, which is designed and made in Taiwan, featuring a patented interlocking design, certified by German LFGB, with heat resistance up to 220°C.Exhibitor at the Stationery & School Supplies Fair showcases a school backpack with a fused lunch bag, featuring a spacious main compartment for books and supplies, while the integrated lunch bag keeps snacks fresh and easily accessible.Fair WebsitesHKTDC Hong Kong Toys & Games Fair: hktoyfair.hktdc.comHKTDC Hong Kong Baby Products Fair: hkbabyfair.hktdc.comHong Kong International Stationery & School Supplies Fair: hkstationeryfair.comRegister for free entry pass: https://tinyurl.com/eb3w32p8Media enquiresPlease contact HKTDC’s Communication & Public Affairs Department:Sharon HaTel:2584 4575Email:sharon.mt.ha@hktdc.orgJane CheungTel:2584 4137 Email:jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 51 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Jan 2, 2025 - (ACN Newswire via SeaPRwire.com) – Strategic Public Relations Group (“SPRG” or the “Group”) proudly announces its transition into its 30th year of development – a significant milestone in its business journey. To celebrate, the Group will organise various events and activities, including a 30th Anniversary Logo Design Contest that was held at the end of 2024. The logo with the “30” and globe will be used in various SPRG materials in 2025 and represent the Group’s commitment to delivering the best services to clients via its global reach and international talent pool. To kick off the anniversary of SPRG, colleagues are offered bubble tea, refreshments and massages on their first working day of the new year.Richard Tsang, Founder and Chairman of SPRG, said, “The chewy bubbles represent pearls, which fit perfectly with our 30th anniversary theme. Just as pearls take time to form and develop their lustre, SPRG has over time developed and grown in stature. In the past 30 years, we have navigated a complex and ever-changing global political and economic landscape. We have had to face each challenge with agility, resilience and unwavering commitment, and these qualities have enabled SPRG to evolve from a local office in Hong Kong into one of the largest PR groups in the APAC region, boasting a cohesive family of 20 member companies. This evolution has enabled us to expand our services beyond a strong foundation in financial services to a broader range of integrated solutions, setting us apart in a dynamic marketplace.”SPRG has consistently bolstered its presence and scope while remaining committed to delivering exceptional services and pursuing continuous advancement. In 2024, the Group added research capabilities as its latest offering, which will be led by a university professor specialising in research, particularly on environmental, social, and governance (ESG) issues. With academic backing and an in-depth understanding of global trends, SPRG will conduct targeted surveys and research to provide tailored solutions to clients and the community. SPRG believes that such endeavours will not only meet the evolving needs of existing clients, but will also attract new ones, as well as further diversify the Group’s service offerings.In line with its service diversification efforts, SPRG launched Strategic DigitaLab (SDL) In 2024, the Group took a significant step forward by refreshing the SDL brand image. With exceptional storytelling capabilities, SDL excels across multiple platforms, attracting clients seeking large-scale content creation services that engage and inspire their target audiences. By harnessing collaborative creativity and digital expertise, SPRG is well positioned to seize early opportunities and meet the demands of major clients in this rapidly evolving landscape.In 2024, SPRG also sharpened its competitive edge by acquiring full ownership of Financial & Corporate Relations Pty Limited (FCR), an IR/financial communications agency with a 40-year legacy based in Sydney, Australia. This acquisition enhances the Group's ability to serve clients in the southern hemisphere, and SPRG looks forward to achieving breakthroughs with FCR's support.SPRG’s commitment to excellence has resulted in over 540 awards and accolades received since its inception, including Asia Pacific Network of the Year, Public Relations Agency of the Year in Asia Pacific, Public Relations Agency of the Year in Asia, Greater China Independent Agency of the Year, Hong Kong Consultancy of the Year, Asia Pacific Financial Consultancy of the Year, Best Crisis Management Team, and Market Leadership in Public Relations, etc. “We would not be celebrating our 30th anniversary and the many successes that have come without the steadfast dedication and teamwork of our colleagues”, said Richard. “As SPRG embarks on a new chapter of development, we will remain committed to excellence and innovation in the public relations industry. In the future, we will continue to enhance service offerings, embrace automation and technology, and offer training and exposure to our teams. The Group is also a staunch advocate of corporate citizenship and will continue to be actively involved in charitable initiatives and pro bono projects that benefit society.”About Strategic Public Relations Group (“SPRG”)Established in 1995 as an investor relations specialist in Hong Kong, SPRG has grown to become an integrated PR group that prides itself on providing exceptional services to local and international clients in Asia Pacific. SPRG has 250 professionals working from eight locations across APAC, providing clients with holistic communications services. With affiliates around the world and PROI Worldwide partners, SPRG can help clients access over 165 cities globally. Visit www.sprg.asia for more information.EnquiriesStrategic Public Relations GroupEveline WANTel: (852) 2864 4822Email: eveline.wan@sprg.com.hkWebsite: www.sprg.asiaHong Kong | Beijing | Shanghai | Guangzhou | Taipei | Singapore | Kuala Lumpur | Sydney Copyright 2025 ACN Newswire via SeaPRwire.com.

SHANGHAI, China - January 2, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that with the official implementation of the latest update of the National Reimbursement Drug List ("NRDL") on January 1, 2025, NEFECON(R) will apply the NRDL pricing, which will benefit more IgA nephropathy (IgAN) patients.NEFECON(R) was included in the NRDL in November 2024. As the first IgAN etiological treatment drug fully approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), NEFECON(R) received NDA approval from the National Medical Products Administration (NMPA) of China in November 2023 through Priority Review. It is the only approved treatment for primary IgAN in adults at risk of disease progression in China.Based on policies in various provinces and cities, NEFECON(R) will be eligible for NRDL reimbursement starting in January. Patients will be able to obtain the medication at designated medical institutions or pharmacies and benefit from the reimbursed pricing. The official implementation of the NRDL will expand the accessibility of NEFECON(R), alleviate the financial burden on patients, and enable more IgAN patients in China to benefit from this innovative drug.Results from the Chinese population of the Phase 3 clinical study NefIgArd study shows that NEFECON(R) reduces kidney function decline by 66%, and delays disease progression to dialysis or kidney transplantation by 12.8 years. With its innovative mechanism of action and clinical advantages, NEFECON(R) has been recommended by several authoritative treatment guidelines. Most recently, it was included in the KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephrophthy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (Public Review Draft), issued by the kidney disease: Improving Global Outcomes (KDIGO) organization.About NEFECON(R)NEFECON(R) is a patented oral, delayed release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity that undergoes substantial first pass metabolism. The formulation is designed as a delayed release capsule that is enteric coated so that it remains intact until it releases budesonide to the distal ileum. Each capsule contains coated beads of budesonide that target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models.In June 2019, Everest Medicines entered into an exclusive, royalty-bearing license agreement with Calliditas Therapeutics, which gives Everest Medicines exclusive rights to develop and commercialize NEFECON(R) in mainland China, Hong Kong, Macau, Taiwan, China and Singapore. The agreement was extended in March 2022 to include South Korea as part of Everest Medicine's territories.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website atwww.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as 'will,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'confident' and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2025 ACN Newswire via SeaPRwire.com.